Effect of oral potassium supplements on urinary kallikrein excretion in Sheehan's syndrome.
López
J M
JM
Mahana
D
D
Rodríguez
J A
JA
Michaud
P
P
Arteaga
E
E
Fardella
C
C
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D002216:Captopril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007018:Hypopituitarism / Q000652:urine*; D007610:Kallikreins / Q000652:urine*; D008875:Middle Aged; D011188:Potassium / Q000008:administration & dosage*
D000804:Angiotensin II; D000450:Aldosterone; D002216:Captopril; D007610:Kallikreins; D011188:Potassium; D006854:Hydrocortisone